These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
36. Pharmacokinetic Profile of ∆9-Tetrahydrocannabinol, Cannabidiol and Metabolites in Blood following Vaporization and Oral Ingestion of Cannabidiol Products. Bergeria CL; Spindle TR; Cone EJ; Sholler D; Goffi E; Mitchell JM; Winecker RE; Bigelow GE; Flegel R; Vandrey R J Anal Toxicol; 2022 Jul; 46(6):583-591. PubMed ID: 35438179 [TBL] [Abstract][Full Text] [Related]
37. Acute effects of cannabinoids on addiction endophenotypes are moderated by genes encoding the CB1 receptor and FAAH enzyme. Hindocha C; Freeman TP; Schafer G; Gardner C; Bloomfield MAP; Bramon E; Morgan CJA; Curran HV Addict Biol; 2020 May; 25(3):e12762. PubMed ID: 31013550 [TBL] [Abstract][Full Text] [Related]
38. A Randomized, Triple-Blind, Comparator-Controlled Parallel Study Investigating the Pharmacokinetics of Cannabidiol and Tetrahydrocannabinol in a Novel Delivery System, Solutech, in Association with Cannabis Use History. Berl V; Hurd YL; Lipshutz BH; Roggen M; Mathur EJ; Evans M Cannabis Cannabinoid Res; 2022 Dec; 7(6):777-789. PubMed ID: 35787693 [No Abstract] [Full Text] [Related]
39. Effect of prior foot shock stress and Δ Rock EM; Limebeer CL; Petrie GN; Williams LA; Mechoulam R; Parker LA Psychopharmacology (Berl); 2017 Jul; 234(14):2207-2217. PubMed ID: 28424834 [TBL] [Abstract][Full Text] [Related]
40. Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta-analysis. Freeman TP; Craft S; Wilson J; Stylianou S; ElSohly M; Di Forti M; Lynskey MT Addiction; 2021 May; 116(5):1000-1010. PubMed ID: 33160291 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]